Elisa Annie Aquilanti, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Telomerase | 4 | 2024 | 745 | 1.910 |
Why?
|
Glioblastoma | 5 | 2024 | 3483 | 0.970 |
Why?
|
Brain Neoplasms | 7 | 2022 | 9032 | 0.740 |
Why?
|
Glioma | 3 | 2023 | 3455 | 0.560 |
Why?
|
Drug Discovery | 1 | 2024 | 1051 | 0.540 |
Why?
|
Central Nervous System Neoplasms | 1 | 2024 | 916 | 0.520 |
Why?
|
Enzyme Inhibitors | 2 | 2024 | 3713 | 0.460 |
Why?
|
Telomere | 2 | 2024 | 943 | 0.290 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2018 | 8554 | 0.210 |
Why?
|
Lomustine | 1 | 2022 | 60 | 0.210 |
Why?
|
Oligonucleotides | 1 | 2024 | 582 | 0.190 |
Why?
|
Pathology, Molecular | 1 | 2023 | 328 | 0.180 |
Why?
|
Cryoelectron Microscopy | 1 | 2024 | 650 | 0.180 |
Why?
|
Promoter Regions, Genetic | 3 | 2021 | 5790 | 0.170 |
Why?
|
Drug Design | 1 | 2024 | 1048 | 0.160 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2022 | 617 | 0.160 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2018 | 638 | 0.150 |
Why?
|
DNA Modification Methylases | 1 | 2018 | 210 | 0.150 |
Why?
|
Neoplasms | 2 | 2024 | 22173 | 0.150 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2018 | 350 | 0.140 |
Why?
|
Tumor Burden | 1 | 2023 | 1892 | 0.140 |
Why?
|
Mutation | 7 | 2024 | 30053 | 0.140 |
Why?
|
Immunotherapy | 2 | 2024 | 4652 | 0.140 |
Why?
|
DNA Repair Enzymes | 1 | 2018 | 346 | 0.140 |
Why?
|
Lymphoma | 1 | 2024 | 1901 | 0.120 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13381 | 0.100 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 938 | 0.100 |
Why?
|
Antineoplastic Agents | 3 | 2024 | 13642 | 0.100 |
Why?
|
Medical Oncology | 1 | 2023 | 2321 | 0.100 |
Why?
|
Genes, Essential | 1 | 2012 | 185 | 0.090 |
Why?
|
Gene Deletion | 1 | 2018 | 2665 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 2 | 2018 | 2805 | 0.090 |
Why?
|
Combined Modality Therapy | 1 | 2022 | 8527 | 0.090 |
Why?
|
RNA-Binding Protein FUS | 1 | 2010 | 76 | 0.090 |
Why?
|
Humans | 13 | 2024 | 761596 | 0.080 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4915 | 0.080 |
Why?
|
Prognosis | 2 | 2020 | 29629 | 0.080 |
Why?
|
Sequence Deletion | 1 | 2012 | 1494 | 0.070 |
Why?
|
DNA Methylation | 2 | 2018 | 4399 | 0.070 |
Why?
|
RNA Splicing | 1 | 2010 | 918 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9280 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5314 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5709 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2012 | 2811 | 0.050 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2020 | 102 | 0.040 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2010 | 1469 | 0.040 |
Why?
|
Genes, myc | 1 | 2020 | 390 | 0.040 |
Why?
|
Mice, Nude | 1 | 2020 | 3614 | 0.030 |
Why?
|
Phosphonoacetic Acid | 1 | 2012 | 54 | 0.030 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2012 | 127 | 0.030 |
Why?
|
Cell Line | 2 | 2020 | 15601 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 2020 | 0.020 |
Why?
|
Adenovirus E1A Proteins | 1 | 2010 | 74 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4281 | 0.020 |
Why?
|
Hydroxamic Acids | 1 | 2012 | 481 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2009 | 15936 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2012 | 2016 | 0.020 |
Why?
|
Cytoplasmic Granules | 1 | 2010 | 574 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2012 | 1062 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1612 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2024 | 5672 | 0.020 |
Why?
|
Homozygote | 1 | 2012 | 1776 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2009 | 1302 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2009 | 662 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 2065 | 0.020 |
Why?
|
Genomics | 1 | 2020 | 5821 | 0.010 |
Why?
|
Mice | 3 | 2020 | 81539 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2009 | 1745 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3430 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22176 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2010 | 3733 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4576 | 0.010 |
Why?
|
Transcription Factors | 1 | 2020 | 12130 | 0.010 |
Why?
|
Animals | 3 | 2020 | 168475 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2009 | 3617 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2012 | 10451 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2009 | 4415 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 16990 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9610 | 0.010 |
Why?
|
Male | 1 | 2020 | 360846 | 0.000 |
Why?
|
Female | 1 | 2020 | 392705 | 0.000 |
Why?
|
Child | 1 | 2009 | 80158 | 0.000 |
Why?
|
Adult | 1 | 2009 | 221210 | 0.000 |
Why?
|